Quick Answer
BIOLIFE SOLUTIONS INC reported Diluted EPS of $0.10 per share (loss) for fiscal year 2025.
BIOLIFE SOLUTIONS INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.10 | +77.3% |
| 2024 | -$0.44 | +71.6% |
| 2023 | -$1.55 | +52.3% |
| 2022 | -$3.25 | -1313.0% |
| 2021 | -$0.23 | -283.3% |
| 2020 | -$0.06 | +33.3% |
| 2019 | -$0.09 | -164.3% |
| 2018 | $0.14 | +166.7% |
| 2017 | -$0.21 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.01 | +125.0% | +103.0% |
| June 30, 2025 | -$0.33 | +26.7% | -3200.0% |
| March 31, 2025 | -$0.01 | +95.5% | +75.0% |
| September 30, 2024 | -$0.04 | +94.0% | +91.1% |
| June 30, 2024 | -$0.45 | -95.7% | -104.5% |
| March 31, 2024 | -$0.22 | +31.2% | +67.2% |
| September 30, 2023 | -$0.67 | -179.2% | -191.3% |
| June 30, 2023 | -$0.23 | +86.6% | +28.1% |
- BIOLIFE SOLUTIONS INC showed an increase of +77.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2017–2025 period, BIOLIFE SOLUTIONS INC’s diluted eps has grown by 52.4% (from $0.21 per share (loss) to $0.10 per share (loss)).
- The most recent figure is from BIOLIFE SOLUTIONS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: